HLS

Healius

Health Care Equipment & Services

Healius is a leading Australian diagnostics company providing essential healthcare services through a vast network of labs and diagnostic centers. With a focus on accessible and affordable healthcare, Healius leverages digital technologies to enhance service delivery and patient care.

Diagnostics

Healthcare

ASX

Pathology

Shorted

short percentage4.99%

reported shorts36.3M

shares on issue726.133M

Shorted

short percentage

reported short positions

total shares on issue

About

website

healius.com.au

industry

Health Care Equipment & Services

address

Level 22, 161 Castlereagh Street, SYDNEY, NSW, AUSTRALIA, 2000

Connect

Key Metrics

market cap

$668.04M

eps$-0.78

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

View all stocks in this industry

Short Position Trends

Track bearish sentiment and short interest over time

Historical Price Data

View stock price movements, volume, and trading patterns

Industry & Focus

Diagnostics

Healthcare

ASX

Pathology

Australia

Company Overview

AI-generated company summary

Company History

Healius was founded over 30 years ago and has grown to become a major player in the Australian healthcare sector. Initially focused on pathology services, the company has expanded its offerings to include a wide range of diagnostic services. Over the years, Healius has established over 2,000 collection centers and employs more than 6,100 team members, solidifying its position as a key healthcare provider in Australia.

Competitive Advantages

Healius boasts a comprehensive network of diagnostic centers across Australia, providing widespread accessibility. The company's investment in digital technologies enhances service efficiency and patient outcomes. Additionally, Healius's long-standing industry presence and expertise in pathology services give it a competitive edge.

Risk Factors

•Regulatory changes in healthcare
•Technological disruptions
•Market competition

Recent Developments

Last 6 months

In the past six months, Healius has launched a national awareness campaign for pharmacogenomic testing and released its inaugural diabetes report, highlighting the importance of early intervention in managing the disease.

Key People

Leadership team at Healius

Paul Anderson

CEO

Paul Anderson is the Managing Director and Chief Executive Officer of Healius, driving innovation and growth within the company.

Andrew Thomson

CFO

Andrew Thomson serves as the Chief Financial Officer, overseeing the financial operations and strategic financial planning of Healius.

Financial Reports

10 reports available

Sustainability Report 2025November 11, 2025View

Financial ReportDec 31, 2025via crawler

FY25 Results PresentationAugust 21, 2025View

Financial ReportDec 31, 2025via crawler

1H25 Results PresentationFebruary 20, 2025View

Financial ReportDec 31, 2025via crawler

Annual report 2024September 19, 2024View

Annual ReportDec 31, 2024via crawler

Sustainability Report 2024September 19, 2024View

Financial ReportDec 31, 2024via crawler

FY24 Results PresentationAugust 21, 2024View

Financial ReportDec 31, 2024via crawler

HY24 Half Year Results PresentationFebruary 27, 2024View

Financial ReportDec 31, 2024via crawler

Tax Transparency Report 2023November 15, 2023View

Financial ReportDec 31, 2023via crawler

1H23 Results PresentationSeptember 27, 2023View

Financial ReportDec 31, 2023via crawler

FY23 results presentationAugust 30, 2023View

Financial ReportDec 31, 2023via crawler